Skip to main content

37 Percent Diagnosed With Type 1 Diabetes After Age 30

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 25, 2023 -- Diagnosis of type 1 diabetes often occurs after age 30 years, more so in men and racial/ethnic minorities, according to a research letter published online Sept. 26 in the Annals of Internal Medicine.

Michael Fang, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues characterized the age distribution of type 1 diabetes diagnosis in the United States using data from the National Health Interview Survey (NHIS). Data were included from 947 adults with type 1 diabetes in NHIS cycles from 2016 to 2022, representing about 1.3 million U.S. adults.

The researchers found that the distribution of age at diagnosis of type 1 diabetes was right-skewed, reaching a peak around 15 years of age. The median age at diagnosis was 24 years, with later diagnosis for men than women (median, 27 versus 22 years) and for racial/ethnic minorities versus non-Hispanic White adults (median, 26 to 30 years versus 21 years). Diagnosis after age 30 years occurred in 37 percent of participants, with higher rates seen for men and for racial/ethnic minorities.

"The onset of type 1 diabetes during adulthood is common, particularly in men and racial/ethnic minority patients," the authors write. "Tools integrating clinical measures and biomarkers may improve the accuracy of diagnosis for these patients."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

Sociodemographics Tied to Rehab Use During Critical Illness Hospitalization

FRIDAY, May 10, 2024 -- For older adults hospitalized with a stay in the intensive care unit (ICU), social determinants of health (SDOH) are associated with use of skilled...

Breakthrough Gene Therapy Enables Infant Born Deaf to Hear

FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...

Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure

FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.